C/EBPα in Normal and Malignant Myelopoiesis

Overview

Journal Int J Hematol

Specialty Hematology

Date 2015 Mar 11

PMID 25753223

Citations 58

Authors

Alan D Friedman

Affiliations

Soon will be listed here.

Abstract

CCAAT/enhancer binding protein α (C/EBPα) dimerizes via its leucine zipper (LZ) domain to bind DNA via its basic region and activate transcription via N-terminal trans-activation domains. The activity of C/EBPα is modulated by several serine/threonine kinases and via sumoylation, its gene is activated by RUNX1 and additional transcription factors, its mRNA stability is modified by miRNAs, and its mRNA is subject to translation control that affects AUG selection. In addition to inducing differentiation, C/EBPα inhibits cell cycle progression and apoptosis. Within hematopoiesis, C/EBPα levels increase as long-term stem cells progress to granulocyte-monocyte progenitors (GMP). Absence of C/EBPα prevents GMP formation, and higher levels are required for granulopoiesis compared to monopoiesis. C/EBPα interacts with AP-1 proteins to bind hybrid DNA elements during monopoiesis, and induction of Gfi-1, C/EBPε, KLF5, and miR-223 by C/EBPα enables granulopoiesis. The CEBPA ORF is mutated in approximately 10 % of acute myeloid leukemias (AML), leading to expression of N-terminally truncated C/EBPαp30 and C-terminal, in-frame C/EBPαLZ variants, which inhibit C/EBPα activities but also play additional roles during myeloid transformation. RUNX1 mutation, CEBPA promoter methylation, Trib1 or Trib2-mediated C/EBPαp42 degradation, and signaling pathways leading to C/EBPα serine 21 phosphorylation reduce C/EBPα expression or activity in additional AML cases.

Citing Articles

Free fatty acids may regulate the expression of 11β-hydroxysteroid dehydrogenase type 1 in the liver of high-fat diet golden hamsters through the ERS-CHOP-C/EBPα signaling pathway.

Liu D, Tian P, Hou Y, Zhang T, Hou X, Liu L Lipids Health Dis. 2025; 24(1):40.

PMID: 39920773 PMC: 11806826. DOI: 10.1186/s12944-025-02461-5.

Cebpa is required for haematopoietic stem and progenitor cell generation and maintenance in zebrafish.

Chen K, Wu J, Zhang Y, Liu W, Chen X, Zhang W Open Biol. 2024; 14(11):240215.

PMID: 39500381 PMC: 11537755. DOI: 10.1098/rsob.240215.

Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins.

Liongue C, Ward A Cancers (Basel). 2024; 16(2).

PMID: 38254802 PMC: 10813624. DOI: 10.3390/cancers16020313.

The RNA mA demethylase ALKBH5 drives emergency granulopoiesis and neutrophil mobilization by upregulating G-CSFR expression.

Liu Y, Song R, Lu Z, Zhao L, Zhan X, Li Y Cell Mol Immunol. 2023; 21(1):6-18.

PMID: 38114747 PMC: 10757716. DOI: 10.1038/s41423-023-01115-9.

Understanding blood development and leukemia using sequencing-based technologies and human cell systems.

Heuts B, Martens J Front Mol Biosci. 2023; 10:1266697.

PMID: 37886034 PMC: 10598665. DOI: 10.3389/fmolb.2023.1266697.

References

Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z . PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nat Genet. 2007; 40(1):51-60. DOI: 10.1038/ng.2007.7. View

Williams S, Cantwell C, Johnson P . A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 1991; 5(9):1553-67. DOI: 10.1101/gad.5.9.1553. View

Ptasinska A, Assi S, Mannari D, James S, Williamson D, Dunne J . Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. 2012; 26(8):1829-41. PMC: 3419980. DOI: 10.1038/leu.2012.49. View

Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler W . C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell. 2001; 8(4):817-28. DOI: 10.1016/s1097-2765(01)00366-5. View

Vinson C, SIGLER P, McKnight S . Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science. 1989; 246(4932):911-6. DOI: 10.1126/science.2683088. View

Paz-Priel I, Ghosal A, Kowalski J, Friedman A . C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters. Leukemia. 2008; 23(2):365-74. PMC: 2640433. DOI: 10.1038/leu.2008.297. View

Behre G, Singh S, Liu H, Bortolin L, Christopeit M, Radomska H . Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248. J Biol Chem. 2002; 277(29):26293-9. DOI: 10.1074/jbc.M202301200. View

Fukuchi Y, Shibata F, Ito M, Goto-Koshino Y, Sotomaru Y, Ito M . Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha. EMBO J. 2006; 25(14):3398-410. PMC: 1523173. DOI: 10.1038/sj.emboj.7601199. View

Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M, Nervi C . A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005; 123(5):819-31. DOI: 10.1016/j.cell.2005.09.023. View

10.

Lin F, MacDougald O, Diehl A, Lane M . A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A. 1993; 90(20):9606-10. PMC: 47618. DOI: 10.1073/pnas.90.20.9606. View

11.

Rekhtman N, Radparvar F, Evans T, SKOULTCHI A . Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999; 13(11):1398-411. PMC: 316770. DOI: 10.1101/gad.13.11.1398. View

12.

Jack G, Zhang L, Friedman A . M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood. 2009; 114(10):2172-80. PMC: 2744575. DOI: 10.1182/blood-2008-11-191536. View

13.

Zhang H, Alberich-Jorda M, Amabile G, Yang H, Staber P, Di Ruscio A . Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia. Cancer Cell. 2013; 24(5):575-88. PMC: 4038627. DOI: 10.1016/j.ccr.2013.09.018. View

14.

Zhang P, Behre G, Pan J, Iwama A, Wara-Aswapati N, Radomska H . Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci U S A. 1999; 96(15):8705-10. PMC: 17580. DOI: 10.1073/pnas.96.15.8705. View

15.

Paz-Priel I, Cai D, Wang D, Kowalski J, Blackford A, Liu H . CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Mol Cancer Res. 2005; 3(10):585-96. DOI: 10.1158/1541-7786.MCR-05-0111. View

16.

Kim J, Cantwell C, Johnson P, Pfarr C, Williams S . Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J Biol Chem. 2002; 277(41):38037-44. DOI: 10.1074/jbc.M207235200. View

17.

Umek R, Friedman A, McKnight S . CCAAT-enhancer binding protein: a component of a differentiation switch. Science. 1991; 251(4991):288-92. DOI: 10.1126/science.1987644. View

18.

Rangatia J, Vangala R, Treiber N, Zhang P, Radomska H, Tenen D . Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol Cell Biol. 2002; 22(24):8681-94. PMC: 139872. DOI: 10.1128/MCB.22.24.8681-8694.2002. View

19.

Skokowa J, Cario G, Uenalan M, Schambach A, Germeshausen M, Battmer K . LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med. 2006; 12(10):1191-7. DOI: 10.1038/nm1474. View

20.

Hock H, Hamblen M, Rooke H, Traver D, Bronson R, Cameron S . Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity. 2003; 18(1):109-20. DOI: 10.1016/s1074-7613(02)00501-0. View